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ABSTRACT
Sepsis triggers immune responseboth pro-inflammatory and anti-inflammatory. 
Lymphocytes play an important role in the regulation of the inflammatory response. 
The decrease in lymphocyte numbers due to continuous apoptosis by sepsiscan 
suppress the immune system and failure to resolve inflammation. Persistent 
lymphopenia is also associated with a poor prognosis of sepsis. Currently, there 
are limited studies about persistent lymphopenia in sepsis patients in low- and 
middle-income countries, including Indonesia. This study aimed to describe the 
sociodemographic, clinical, and laboratory patterns of sepsis patients with persistent 
lymphopenia. This was a descriptive study that analyzed patients’ medical records 
who were treated at the Department of Internal Medicine, Dr. Sardjito General 
Hospital, Yogyakarta from January 1st, 2016, to December 31th, 2017. Patients 
diagnosed with clinical sepsis and persistent lymphopenia were included in the 
study. The status of persistent lymphopenia was described as lymphocyte counts 
that remained low or lower (<1.62x103/L) on day 4± 24 h compared to the initial 
value at the time of sepsis diagnosis (day one). Information of patients’ individual 
and clinical characteristics, complete blood cell count profiles and culture results 
were included. The outcomes of interest were the survival status and length of stay 
of the patients. A total of 101 patients with sepsis and persistent lymphopenia were 
involved in this study. The average increase in lymphocyte numbers was 73.63 ± 
426.86/µL. The main source of infection was pulmonary infection, with a mortality 
rate of 43.6% and a median survival of 19 days. The average length of stay was 
13.1±6.8. Persistent lymphopenia in patients with sepsis has a high mortality. 
Further research is needed to determine the clinical ramifications of persistent 
lymphopenia.
ABSTRAK
Sepsis memicu timbulnya mekanisme imun yang bersifat pro-inflamasi dan anti-
inflamasi. Limfosit memerankan peranan penting dalam regulasi respon inflamasi, 
dan menurunnya jumlah limfosit karena apoptosis berkelanjutan akibat sepsis 
mengarahkan pada supresi system imun dan gagalnya resolusi dari inflamasi. 
Persistensi limfopenia juga dihubungkan dengan prognosis yang buruk. Sampai 
saat ini, penelitian terkait limfopenia persisten pada pasien sepsis di negara 
berkembang termasuk di Indonesia masih terbatas. Penelitian ini bertujuan untuk 
menggambarkan pola sosiodemografis, klinis, dan laboratoris pasien sepsis dengan 
limfopenia persisten. Penelitian ini adalah penelitian deskriptif dengan menganalisa 
rekam medis pasien yang dirawat di Departemen Ilmu Penyakit Dalam, RSUP DR. 
Sardjito antara 1 Januari 2016 sampai 31 Desember 2017. Pasien dengan klinis 
sepsis dan limfopenia persisen dilibatkan dalam penelitian ini. Kondisi limfopenia 
persisten adalah angka limfosit yang tetap rendah atau lebih rendah (<1,62x103/µL) 
pada hari ke-4 ±24 jam disbanding nilai awal saat diagnosis sepsis (harike-satu). 
Data lain yang disertakan dalam penelitian adalah karakteristik individual dan 
klinis, profil laboratorium, dan hasil kultur. Luaran yang dinilai adalah survival 
dan lama perawatan. Sebanyak 101 pasien sepsis dengan limfopenia persisten 
disertakan dalam penelitian ini. Didapatkan peningkatan rerata angka limfosit 
sebesar 73,63 ± 426,86/µL. Pada pasien dengan limfopenia persistent, didapatkan 
sumber infeksi utama adalah infeksi paru dengan tingkat mortalitas sebesar 
43,6%, dengan median survival mencapai 19 hari. Rerata lama perawatan adalah 
13,1 ±6,8 hari. Limfopenia persisten pada pasien sepsis memiliki mortalitas tinggi. 
Perlu dilakukan penelitian lebih lanjut untuk mengetahui makna klinis limfopenia 
persisten.
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INTRODUCTION
Sepsis triggers the emergence 
ofboth pro- and anti-inflammatory 
immune mechanisms. In general, 
pro-inflammatory reactions aiming 
at eradicating invading pathogens 
are considered responsible for tissue 
damage in severe sepsis. Where as 
anti-inflammatory responses that are 
important to limit local and systemic 
tissue damage are responsible for the 
increased susceptibility of the host to 
secondary  infections.1  Lymphocytes 
play an  important  role in the regulation 
of the inflammatory response. The 
decrease in the number of lymphocytes 
due to continuous apoptosis by sepsis 
leads to suppression of the immune 
system and failure in controlling 
inflammation.2
A study reported that low lymphocyte 
counts have better predictive values for 
bacteremia in patients in the emergency 
unit (ER) compared to C-reactive protein 
(CRP) values, leukocyte or neutrophil 
counts.3 Furthermore, several studies 
showed that circulating lymphocyte 
levels will decrease when sepsis begins 
and can continue to fall until day 
28.4  Persistent lymphopenia is also 
associated with a poor prognosis. It was 
reported that persistent lymphopenia 
on day four after the onset of sepsis 
serves as a predictive factor for survival 
on days 28 and one year after sepsis.5 
However, thestudies assessing persistent 
lymphopenia in low- and middle-income 
countries, including in Indonesia are still 
limited.
Dr. Sardjito General Hospital, 
Yogyakarta, one of the largest university-
affiliated hospitals in Indonesia, is one of 
the main referral hospitals in Indonesia. 
However, no previous study has assessed 
sepsis patients in relation to persistent 
lymphopenia. Specific hospital-based 
assessment would serve as important 
evidence to inform patient clinical 
management and to assess if there are 
any differences in the characteristics 
and predictive factors of mortality 
among sepsis patients. This study aimed 
to determine the clinical patterns, 
sociodemographics and mortality 
of sepsis patients with persistent 
lymphopenia who are treated at the 
Department of Internal Medicine, Dr. 
Sardjito General Hospital, Yogyakarta.
MATERIALS AND METHODS
Subjects
This was a descriptive study 
conducted at the the Department of 
Internal Medicine, Dr.Sardjito General 
Hospital, Yogyakarta. Information of 
patients admitted to the hospital with 
sepsis and persistent lymphopenia who 
were treated by the Department of 
Internal Medicine within the period of 
January 2016 to December 2017 were 
collected. The research subjects were 
admitted either through the emergency 
room or were being treated as inpatients 
who met the inclusion and exclusion 
criteria. All sociodemographic, clinical, 
and laboratory data including culture 
data from the source of infection were 
taken from the medical records.
The inclusion criteria were adult 
patients age 18 years or older who were 
diagnosed with sepsis and persistent 
lymphopenia, were treated in the 
emergency room or inpatient wards 
of the internal medicine department, 
and had data on lymphocyte counts on 
D-1 (day one) and D-4 (day four ± 24 h) 
following the diagnosis. The exclusion 
criteria included comorbidities or other 
factors that may affect lymphocyte 
levels, including HIV  (human 
immunodeficiency virus), malignancy, 
autoimmune diseases, history of G-CSF 
(granulocyte-colony stimulating factors) 
consumption in the past one month, 
as well as history of steroid and/or 
immunosuppressant consumption for 
more than two weeks in the last one 
month.
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Protocol of the study
Diagnosis of sepsis based on SIRS and/
or qSOFA criteria. Diagnosis with SIRS 
criteria was a confirmed or suspected 
infection with at least two of four SIRS 
criteria. Four SIRS criteria were defined: 
tachycardia (heart rate > 90 beats/min), 
tachypnea (respiratory rate >20 breaths/
min), fever or hypothermia (temperature 
> 38 or < 36°C), and leukocytosis or 
leukopenia (white blood cells >1,200/
mm3 or <4,000/mm3). Diagnosis based 
on ‘quick SOFA’ criteria was a modified 
version of the Sequential (Sepsis-related) 
Organ Failure Assessment score. There 
are only three components (respiratory 
rate ≥ 22/min, change in mental status, 
systolic blood pressure ≤100 mmHg) 
that are each allocated one point. A 
qSOFA score of ≥ 2 points indicates organ 
dysfunction.
The lymphocyte count examination 
was obtained from two examinations 
during the treatment period, with the 
first examination carried out when 
a diagnosis of sepsis was established 
(lymphocyte D-1) and the second 
examination within 48-96 h after the 
first examination (lymphocyte D-4). 
Lymphopenia is the total lymphocyte 
number below the normal value that 
the patient has when the diagnosis of 
sepsis is established. The normal value 
based on the hematology examination 
tool used in Dr.Sardjito General Hospital 
Yogyakarta is 1.62-5.37 x 103/L. Persistent 
lymphopenia is a lymphocyteD-4 count 
below normal values.
Statistical analysis
The patient cohort by using 
descriptive statistics, including the 
frequency distributions, mean ± 
standard deviation (SD) and median was 
described. Kaplan-Meier survival curves 
using the log-rank test for patients with 
persistent lymphopenia was created.
RESULTS
There were 101 patients with sepsis 
and persistent lymphopenia who were 
admitted to the Dr. Sardjito General 
Hospital, Yogyakarta between January 
2016 and December 2017 who met 
the inclusion and exclusion criteria. 
Sociodemographic characteristics are 
presented in TABLE 1. There were 
more male patients (65.3%) than female 
patients (34.7%). The mean age was 56.3 
± 15.51 years, where 31.7% of the sample 
were geriatric subjects (> 65 years). Poor 
nutritional status (BMI <18.5 kg/m2) was 
present in 30.7% of subjects.






Age (year) 56.30+ 15.51
•	< 65 years 69 (68.3)
•	≥ 65 years 32 (31.7)
Nutritional Status
•	BMI < 18.5 kg/m2 31 (30.7)
•	BMI ≥ 18.5 kg/m2 70 (69.3)
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The mean lymphocyte D-1count 
was 802.10 ± 359.89/µL, and the mean 
D-4 lymphocyte D-4 count was 875.74 ± 
356.37/µL, and the increase in the average 
lymphocyte counts was only 73.63/µL 
± 426.86 (TABLE 2). Hypoalbuminemia 
occurred in 78.2% of subjects with an 
average albumin level of 2.76 ± 0.77 g/dL.
Only 89 (88.1%) subjects had culture 
data and material sensitivity from the 
source of infection, while the remaining 
11.9% did not have culture data. From the 
available culture data, pathogen growth 
was 62%. The most common pathogens 
were gram negative (38.6%), followed by 
gram positive (32.7%) and fungi (18%), 
with polymicrobial infections (pathogens 
>1 type) occurring as much as 24.8%.
TABLE 2. Laboratory characteristics of sepsis patients with 
persistent lymphopenia
Characteristics n(%)/mean±SD/median
Lymphocytes D-1 (/µL) 802.1±359.89[833.3(172.1 – 1560.78)]
Lymphocytes D-4 (/µL) 875.74± 356.37[896.72(137.69 – 1600.1)]
Lymphocyte Mean Difference (/µL) 73.63±426.86
Albumin value (g/dL) 2.76 ± 0.77
Albumin Category
•	 Low (<3.4 g/dL) 79 (78.2)
•	 Normal (> 3.4 g/dL) 22 (21.8)
Culture Data
•	 Yes 89 (88.1)
•	 None 12 (11.9)
Culture positive results* 62 (61.4)
•	 Gram positive 33(32.7)
•	 Gram negative 39 (38.6)
•	 Fungal 18 (17.8)
•	 Polymicrobial (>1) 25 (24.8)
Culture negative results 39 (38.6)
*percentage>100% because there were more than one event in 
one subject
The clinical characteristics of 
the study subjects are presented in 
TABLE 3. The most common criteria 
for the diagnosis of sepsis was systemic 
inflammatory response syndrome (SIRS)
in 70.6% of patients. This is consistent 
with the knowledge that new SOFA 
(Sequential Organ Failure Assessment) 
criteria were introduced in the consensus 
in 2015 and began to be widely used 
in 2018. The provision of combination 
antibiotics occurred in 87.1% of subjects, 
and only 12.9% of subjects received a 
single antibiotic.
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•	 SIRS + SOFA 20(19.8)
Antibiotic combination 88(87.1)
Source of infection*
•	 Respiratory tract 75(74.3
•	 Urinary tract 35(34.7)
•	 Abdominal 14(13.9)
•	 Skin and soft tissue 28(27.7)
•	 Others 8(7.9)
Multiple sources (>1) 49 (48.5)
Comorbid*
•	 DM 33 (32.7)
•	 CKD 24 (23.8)
•	 Stroke 6 (5.9)
•	 Cirrhosis                                8 (7.9)
•	 Heart failure 16 (15.8)
•	 COPD 13 (12.9)
•	 Hypertension 27 (26.7)
•	 Depression 8 (7.9)
Multiple comorbids (≥2) 33 (32.7)
Shock 30 (29.7)
Length of stay (days) 13.06 ± 6.77
Outcome
•	 Alive 57 (56.4)
•	 Dead 44 (43.6)
* Percentage > 100% because there were 
more than one event in one subject
The main source of infection in 
this study was lung and respiratory 
infection (74.3%), followed by urinary 
tract infection (34.7%) and skin and 
soft tissue infections (27.7%). Multiple 
sources of infections were found in 
48.5% of subjects. The most common 
comorbidities were diabetes mellitus 
(DM), hypertension, and chronic kidney 
disorders (CKD). Multiple comorbidities 
were found in 32.7% of the study subjects. 
Thirty subjects (29.7%) experienced 
septic shock and/or had vasopressors. 
The mortality rate was 43.6%. The 
average duration of treatment reached 
13.06 ± 6.77 days. Median survival of 
the whole subject during treatment is 
presented in FIGURE 1, reaching 19 days.
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FIGURE 1. Median survival of sepsis patients withpersistent 
lymphopenia
DISCUSSION
In this study, male research subjects 
were more common than female 
research subjects. The mean age was 
56.3 ± 15.51 years, with 31.7% of subjects 
being geriatric. Age and gender as risk 
factors for sepsis have been known from 
various studies. A previous study showed 
a higher incidence of sepsis in men at up 
to 1.8 times that of women, and mortality 
increased with increasing age over 40 
years.6 Ageing is an independent risk 
factor for sepsis.7
Additional risk factors include 
malnutrition, chronic diseases, 
immunosuppression, surgery or 
hospitalization and the use of catheters 
or other medical devices. We also 
observed a similar pattern in which poor 
nutritional status was found in 30.7% of 
the study subjects. Hypoalbuminemia 
occurred in 78.2% of subjects, and 
the large number of subjects with low 
albumin levels can be associated with the 
pathophysiology of hypoalbuminemia 
in sepsis. In sepsis, endothelial damage 
increases trans-capillary albumin losses, 
reaching 13 times from usual.8
The mean value of lymphocytes D-1 in 
the study subjects was 802.10 ± 359.89/L, 
and the lymphocytes D-4 were 875.74 
± 356.37/L. There are several causes of 
lymphopenia in addition to infection, 
such as malnutrition conditions, which 
can affect lymphocyte levels through 
bone marrow hypoplasia.3 Poor 
nutritional status was found in 30.7% 
of the study subjects. Lymphopenia 
is also known to occur in depressed 
patients, although the exact mechanism 
of this relationship is not yet known.9 
A total of 7.9% of the study subjects 
had depression. Other conditions that 
are known to affect lymphocyte levels 
in the blood are heart failure, uremia, 
immunosuppressive conditions such 
as autoimmune disease, malignancy, 
HIV infection, and the use of drugs that 
affect lymphocyte production, such as 
corticosteroids, immunosuppressants, 
G-CSF, radiation, and chemotherapy.10 
In this study, the immunosuppressed 
conditions were part of the exclusion 
criteria.
The main sources of infection found 
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were infection of the lungs, followed 
by urinary tract infection and skin and 
soft tissue infections. This is somewhat 
different from other studies,11 in which 
the main sources of sepsis consecutively 
are pulmonary, urinary and intra-
abdominal infections. The most common 
comorbidities in our subjects were 
DM, hypertension, and CKD. Multiple 
comorbidities were found in 32.7% of the 
study subjects. Chronic disease patients 
experience chronic inflammation, 
which causes an increased risk of 
developing sepsis after exposure to 
infection.Previous study reported that 
the risk of developing sepsis in patients 
with comorbid chronic disease; with 
more comorbidities, the risk is also 
increasing.12 Diabetes mellituswas the 
most comorbid in this study because skin 
and soft tissue infections became the 
third most common source of infection 
(28.5%) in this study. The most common 
type of skin and soft tissue infections in 
this study were diabetic ulcers, which 
were 13 of 28 subjects.
From the available culture and 
sensitivity data, pathogen growth 
was found in 61.4% of subjects. The 
most common pathogens were gram-
negative followed by gram-positive and 
fungal, with polymicrobial infections 
(pathogens> 1 type) occurring as much 
as 24.8%. This is not different from 
other studies, where gram negativity 
was found as the main cause of sepsis.8 
Negative culture results were obtained 
from 38.6% subjects. It is in accordance 
with previousstudy where one-third of 
cultures from all sources of infection 
were negative.1However, previous study 
on sepsis patients at Dr.SardjitoGeneral 
Hospital in 2014, pathogen growth in 
blood cultures was only found in 30.2% 
of patients.13 Negative culture results 
could be caused by several factors, 
including untimely collection of the 
culture materials (e.g., materials taken 
after empirical antibiotics have been 
given), prescriptions of antibiotics for the 
previous treatment period, anaerobic or 
viral or parasitic pathogens that would 
result in negative culture, or errors in the 
sampling and examination procedures.
Thirty subjects (29.7%) experienced 
septic shock and/or had vasopressors. 
The mortality rate in this study 
reached 43.6%, greater than recent 
epidemiological studies in high-income 
countries, where mortality in sepsis 
and septic shock was 17% and 25%, 
respectively.6 The outcome of critically 
ill patients with bacteraemia sepsis 
was associated with age, sex, ethnicity, 
severity of disease at the onset of sepsis, 
comorbidities, source of nosocomial 
infection and initial cause of infection.14
Previous studies showedthe 
association between lymphopenia, 
sepsis and death. The presence of severe 
lymphopenia in septic shock patients 
at ICU admission associated with a 3.5-
fold increase in mortality on day 28.15 
Moreover, thepersistent lymphopenia 
on day 4 after the onset of sepsis was 
a predictive factor for survival on 
days 28 and 1 year. As many as 22% of 
patients died on day28, severe persistent 
lymphopenia (<0.6 x 103/L) was associated 
with increased secondary infections.5
The accumulation of pro-
inflammatory cytokines is associated 
with death in the early phase of sepsis.16 
On the other hand, deaths due to 
sepsis in the later stages are related to 
conditions of suppression and immune 
dysfunction. A previous study17showed 
that most patients who survived the 
early phase of sepsis will enter an 
unresponsive immunological phase, 
which is characterized by a decrease in 
T cell function, indicating the condition 
of immunosuppression or immune 
paralysis. In fact, more than 70% of 
deaths due to sepsis occurred within 
the first 3 days, with subsequent deaths 
occurring within weeks of the onset of 
sepsis.16 In this study, deaths occurred 
in 43.6% of subjects with a mean length 
of stay until the death outcome occurred 
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was 13.06 ± 6.77 days. The median 
survival of the whole subject during 
treatment was 19 days. This is consistent 
with deaths occurring in the later stages 
of sepsis related to immunosuppression 
and persistent lymphopenia.
This study has several limitations. 
First, since we relied on hospital medical 
records, some data were incomplete, 
particularly those pertaining to culture 
data. This may reduce the completeness 
of information. Second, our sample 
population may not necessarily represent 
the general population due to the single-
center nature of our study setting at the 
hospital. Dr. SardjitoGeneral Hospital, a 
tertiary hospital, also has more clinical 
complications than patients at lower-
level hospitals in Indonesia. The strength 
of this study is that selection bias has 
been minimized by exclusion criteria for 
immunosuppression conditions that can 
affect lymphocyte levels.
CONCLUSION
Septic patients with persistent 
lymphopenia have high mortality, and 
further study is needed to investigate 
the clinical ramifications of persistent 
lymphopenia.
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